TimesSquare Capital Management LLC has reduced its stake in IDEXX Laboratories (NASDAQ:IDXX) by 4.1%, but it remains their 6th largest holding, representing 1.8% of their investment portfolio. Other institutional investors have also adjusted their positions in the company. An IDEXX executive recently sold over $7.3 million worth of shares, reducing their ownership by 53.60%. The company reported a slight EPS miss but exceeded revenue expectations for its latest quarter and analysts have a “Moderate Buy” rating with a consensus price target of $783.33.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
IDEXX Laboratories, Inc. $IDXX is TimesSquare Capital Management LLC's 6th Largest Position
TimesSquare Capital Management LLC has reduced its stake in IDEXX Laboratories (NASDAQ:IDXX) by 4.1%, but it remains their 6th largest holding, representing 1.8% of their investment portfolio. Other institutional investors have also adjusted their positions in the company. An IDEXX executive recently sold over $7.3 million worth of shares, reducing their ownership by 53.60%. The company reported a slight EPS miss but exceeded revenue expectations for its latest quarter and analysts have a “Moderate Buy” rating with a consensus price target of $783.33.